GlassScriptPhysician profile
Angela R Kroff
NPI 1427529353
$1,525.16
in general payments reported to CMS, 2019-2025
21 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.51 · 2023: $1,228 · 2024: $66.48 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $356.39 | 2023 | |
| Medtronic, INC. | $139.31 | 2025 | Stealthstation S8 Platform, Anteralign Spinal System With Titan Nanolock Surface Technology, Cd Horizon Spinal System |
| Teva Pharmaceuticals USA, INC. | $107.22 | 2023 | Austedo Xr |
| Ucb, INC. | $102.90 | 2023 | Nayzilam |
| Alexion Pharmaceuticals, INC. | $96.39 | 2023 | Ultomiris |
| Emd Serono, INC. | $92.20 | 2023 | Mavenclad |
| Corium, LLC | $79.84 | 2023 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $78.09 | 2021-2024 | Andexxa |
| Lilly USA, LLC | $75.88 | 2023 | Emgality |
| Pfizer INC. | $64.40 | 2023-2024 | |
| Ironshore Pharmaceuticals INC. | $61.67 | 2023 | Jornay Pm |
| Catalyst Pharmaceuticals, INC. | $46.13 | 2023 | Fycompa |
| Spr Therapeutics, INC | $42.68 | 2025 | Sprint Pns System |
| Sk Life Science, INC. | $39.74 | 2023 | |
| Eisai INC. | $38.50 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $22.62 | 2023 | |
| Csl Behring | $19.38 | 2023 | Hizentra |
| Stryker Corporation | $18.93 | 2024 | Spinejack |
| Scilex Pharmaceuticals INC. | $16.31 | 2023 | Ztlido |
| Sumitomo Pharma America, INC. | $13.51 | 2023 | Aptiom |
| Neos Therapeutics, LP | $13.07 | 2023 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Kroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.